Why consider treatment in China for Hypertrophic Cardiomyopathy?

China offers advanced treatment options for HCM at high-volume cardiac centers, including septal myectomy and percutaneous alcohol septal ablation, performed by highly experienced surgeons. The cost is significantly lower than in Western countries, often 50-70% less, while maintaining comparable quality and safety standards. Many Chinese hospitals are internationally accredited and use state-of-the-art technology, making them a reliable choice for international patients.